NKTR

NASDAQ HEALTHCARE

Nektar Therapeutics

$37.45

$0.23 (+0.62%)

Live quote

52w: $33.40 – $109.00

Loading chart…

P/E Ratio—

P/B Ratio1.42

EV/EBITDA—

Debt/Equity—

ROE-18.17%

ROIC—

Revenue Growth-43.89%

Gross Margin—

Nektar Therapeutics is a biopharmaceutical company. The company is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India.

Own NKTR? Track it here.

Create a free account to add NKTR to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account